Sign in Pull a receipt

RANI

Rani Therapeutics Holdings, Inc.

Healthcare · Biotechnology

$94.96 sample

+1.49 (+1.59%) 1D

Market cap

$230.5B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$94.96 +10.81% 3M daily closessample

95.6882.24

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SECDEF 14A filed
Oct 16INSInsider buy: General Counsel
Oct 13INSInsider buy: Chief Financial Officer
Oct 06INSInsider sell: General Counsel
Sep 29INSInsider buy: 10% owner
Sep 23SEC10-Q filed
Sep 18INSInsider sell: Chief Executive Officer
Sep 11INSInsider sell: Chief Executive Officer

Sign up to see the real RANI record →

Company facts

SEC EDGAR registration

Name: Rani Therapeutics Holdings, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -6sample, -100 to +100
Reporting currency: USD

Who is positioning in RANI

sample

Insiders: 17 insider transactions over 90 days, net selling, $474.0M
Congress: 5 members traded over 90 days
Institutions · 13F: 20 funds hold $1.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$8.3B +24.8% y/y

Q4 2024Q3 2026

Inventory$4.9B +14.1% y/y

Q4 2024Q3 2026

Accounts receivable$3.5B +7.5% y/y

Q4 2024Q3 2026

Total debt$10.0B +13.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $28.9B -11.9% 3M
Sample peer B: $190.2B +8.9% 3M
Sample peer C: $229.5B -9.1% 3M
Sample peer D: $167.9B -5.8% 3M
Sample peer E: $180.4B +0.6% 3M